Letters
Guidance on collaboration with drug industry
An alternative set of principles for consideration
BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e2927 (Published 24 April 2012) Cite this as: BMJ 2012;344:e2927- Tom A Yates, MRC advanced course master’s student in epidemiology1,
- Carl J Reynolds, core trainee year 1 in acute medicine2
- 1London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
- 2Chelsea and Westminster Hospital, London, UK
- thomas.yates{at}lshtm.ac.uk
It is disappointing to see so many reputable organisations join the Association of the British Pharmaceutical Industry (ABPI) in endorsing such a damaging and ill conceived document.1 2 Unreferenced statements such as “Healthcare and industry professionals are able to manage their relationships with each other without compromising clinical decision making,”2 at odds with a growing body of evidence,3 are unhelpful.
We would …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.